Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Tropane-based chemokine CCR5 modulators newly developed at Pfizer

Nov. 17, 2003

Preliminary phase Ib results support antiretroviral activity of TNX-355 for HIV

Nov. 14, 2003

AIDSVAX B/E fails to meet endpoints in phase III HIV trial

Nov. 14, 2003

Positive preliminary results for AVR-118 in cachexia

Nov. 13, 2003

Assessment of the benefits of enfuvirtide in HIV-infected patients

Nov. 13, 2003

Novel HIV protease inhibitors prepared and tested at Pharmacor

Nov. 13, 2003

New pyridoxal-based HIV integrase inhibitors covered by Pharmacor patent

Nov. 13, 2003

EACS presentations cover clinical results for atazanavir

Nov. 12, 2003

Antiviral activity and pharmacokinetics of SPD-754 in HIV infection

Nov. 11, 2003

Durable antiviral response induced by tipranavir in heavily pretreated HIV patients

Nov. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...